Richard Kuntz
CIK: 0001341125
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jul 30, 2026INVE
Identiv, Inc.
Award(A)Direct17.5K shares- - Jun 1, 2026DMAC
DiaMedica Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
40.4K shares- - Oct 20, 2025ZIMV
ZimVie Inc.
Disposition(D)DirectDeferred Share Units
13.1K shares- - Oct 20, 2025ZIMV
ZimVie Inc.
Disposition(D)DirectRestricted Stock Units
57.7K shares- - Sep 30, 2025ZIMV
ZimVie Inc.
Award(A)DirectDeferred Share Units
662 shares- - Jul 29, 2025INVE
Identiv, Inc.
Award(A)Direct21.1K shares- - Jun 30, 2025ZIMV
ZimVie Inc.
Award(A)DirectDeferred Share Units
1.3K shares- - Jun 1, 2025DMAC
DiaMedica Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
32.2K shares- - May 7, 2025ZIMV
ZimVie Inc.
Award(A)DirectDeferred Share Units
500 shares- - May 7, 2025ZIMV
ZimVie Inc.
Award(A)DirectRestricted Stock Units
21.1K shares- - Mar 31, 2025ZIMV
ZimVie Inc.
Award(A)DirectDeferred Share Units
1.2K shares- - Jan 2, 2025DMAC
DiaMedica Therapeutics Inc.
Award(A)Direct9.9K shares at avg. $5.34$53K - Dec 31, 2024ZIMV
ZimVie Inc.
Award(A)DirectDeferred Share Units
895 shares- - Sep 30, 2024ZIMV
ZimVie Inc.
Award(A)DirectDeferred Share Units
795 shares- - Jul 29, 2024INVE
Identiv, Inc.
Award(A)Direct14.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 30, 2026 |  INVE Identiv, Inc. | Award(A) | 17,544 | - | $0 | Direct |
| Jun 1, 2026 |  DMAC DiaMedica Therapeutics Inc. | Award(A) Stock Option (right to buy) | 40,412 | - | - | Direct |
| Oct 20, 2025 |  ZIMV ZimVie Inc. | Disposition(D) Deferred Share Units | 13,073 | - | - | Direct |
| Oct 20, 2025 | ZIMV ZimVie Inc. | Disposition(D) Restricted Stock Units | 57,728 | - | - | Direct |
| Sep 30, 2025 | ZIMV ZimVie Inc. | Award(A) Deferred Share Units | 662 | - | - | Direct |
| Jul 29, 2025 | INVE Identiv, Inc. | Award(A) | 21,148 | - | - | Direct |
| Jun 30, 2025 | ZIMV ZimVie Inc. | Award(A) Deferred Share Units | 1,341 | - | - | Direct |
| Jun 1, 2025 | DMAC DiaMedica Therapeutics Inc. | Award(A) Stock Option (right to buy) | 32,162 | - | - | Direct |
| May 7, 2025 | ZIMV ZimVie Inc. | Award(A) Deferred Share Units | 500 | - | - | Direct |
| May 7, 2025 | ZIMV ZimVie Inc. | Award(A) Restricted Stock Units | 21,119 | - | - | Direct |
| Mar 31, 2025 | ZIMV ZimVie Inc. | Award(A) Deferred Share Units | 1,163 | - | - | Direct |
| Jan 2, 2025 | DMAC DiaMedica Therapeutics Inc. | Award(A) | 9,925 | $5.34 | $53,000 | Direct |
| Dec 31, 2024 | ZIMV ZimVie Inc. | Award(A) Deferred Share Units | 895 | - | - | Direct |
| Sep 30, 2024 | ZIMV ZimVie Inc. | Award(A) Deferred Share Units | 795 | - | - | Direct |
| Jul 29, 2024 | INVE Identiv, Inc. | Award(A) | 14,773 | - | $0 | Direct |
1-15 of 15 transactions
About Kuntz Richard
Kuntz Richard (SEC CIK 0001341125) files insider reports with the SEC as Director of Identiv, Inc. (INVE), Director of DiaMedica Therapeutics Inc. (DMAC) and Director of ZimVie Inc. (ZIMV).
Signal8 holds 13 ownership filings by Kuntz Richard, all Form 4s, filed between Oct 2, 2024 and Aug 3, 2026. Those filings report 15 transactions, from Jul 29, 2024 to Jul 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kuntz Richard's filings is in SANTA ANA, CA.
Recent filings by Kuntz Richard
- Jul 30, 2026: Grant or award of INVE shares (Form 4, code A).
- Jun 1, 2026: Grant or award of DMAC derivative securities (Form 4, code A).
- Oct 20, 2025: Disposition to issuer transactions of ZIMV derivative securities (2 lines, Form 4, code D).
- Sep 30, 2025: Grant or award of ZIMV derivative securities (Form 4, code A).
- Jul 29, 2025: Grant or award of INVE shares (Form 4, code A).
Other insiders filing for Identiv, Inc. (INVE)
- KIRNBAUER EDWARD
- Newquist Kirsten F., Chief Executive Officer
- LOPEZ MIGUEL A, Director
- Angelini Laura, Director
- KREMEN GARY, Director
- OUSLEY JAMES E, Director